• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HMGB1 削弱结直肠癌淋巴结的抗肿瘤转移防御功能。

HMGB1 attenuates anti-metastatic defense of the lymph nodes in colorectal cancer.

机构信息

Department of Molecular Pathology, Nara Medical University School of Medicine, Kashihara, Nara, 634-8521, Japan.

出版信息

Pathobiology. 2010;77(1):17-23. doi: 10.1159/000272950. Epub 2010 Feb 25.

DOI:10.1159/000272950
PMID:20185963
Abstract

BACKGROUND

Cancer-secreted high mobility group 1 (HMGB1) induces apoptosis of macrophages and suppresses the host anti-cancer immune system.

OBJECTIVE

We here examined the effect of HMGB1 on macrophages in the lymph nodes of colorectal cancer (CRC) patients.

METHODS

Regional lymph nodes of 50 Dukes C CRCs were compared with 50 Dukes B CRCs.

RESULTS

Dukes C tumors exhibited higher HMGB1 labeling indices and higher HMGB1 concentrations in primary tumors than Dukes B CRCs. Macrophages in the regional lymph nodes were decreased in non-metastasized nodes as well as metastasized nodes in Dukes C cases, whereas macrophage numbers in Dukes B nodes were higher than in Dukes C nodes. Nodal HMGB1 concentration was higher in Dukes C nodes than in Dukes B nodes, being inversely correlated with macrophage numbers. Nodal HMGB1 concentration was correlated with HMGB1 concentration and lymph vessel density in the primary tumors.

CONCLUSION

These data suggest that HMGB1 secreted from primary tumors spread to the regional lymph nodes decreases the number of macrophages to attenuate the anti-metastatic defense of the lymph nodes in patients with CRCs.

摘要

背景

癌症分泌的高迁移率族蛋白 1(HMGB1)诱导巨噬细胞凋亡,并抑制宿主的抗肿瘤免疫。

目的

本研究旨在探讨 HMGB1 对结直肠癌(CRC)患者淋巴结中巨噬细胞的影响。

方法

对 50 例 Dukes C CRC 患者的区域淋巴结与 50 例 Dukes B CRC 患者的区域淋巴结进行比较。

结果

与 Dukes B CRC 相比,Dukes C 肿瘤的 HMGB1 标记指数和原发肿瘤中的 HMGB1 浓度更高。在非转移性和转移性 Dukes C 病例的区域淋巴结中,巨噬细胞数量减少,而 Dukes B 病例的巨噬细胞数量高于 Dukes C 病例。淋巴结中 HMGB1 的浓度在 Dukes C 淋巴结中高于 Dukes B 淋巴结,与巨噬细胞数量呈负相关。淋巴结中 HMGB1 的浓度与原发肿瘤中的 HMGB1 浓度和淋巴管密度相关。

结论

这些数据表明,源自原发性肿瘤的 HMGB1 扩散到区域淋巴结,减少了巨噬细胞的数量,从而削弱了 CRC 患者淋巴结的抗肿瘤转移防御能力。

相似文献

1
HMGB1 attenuates anti-metastatic defense of the lymph nodes in colorectal cancer.HMGB1 削弱结直肠癌淋巴结的抗肿瘤转移防御功能。
Pathobiology. 2010;77(1):17-23. doi: 10.1159/000272950. Epub 2010 Feb 25.
2
HMGB1 attenuates anti-metastatic defence of the liver in colorectal cancer.HMGB1 削弱了结直肠癌肝脏的抗转移防御。
Eur J Cancer. 2010 Mar;46(4):791-9. doi: 10.1016/j.ejca.2009.11.011. Epub 2009 Dec 16.
3
How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.在杜克B期结直肠癌中应检查多少个淋巴结?基于累积生存率的判定。
Hepatogastroenterology. 2005 Nov-Dec;52(66):1703-6.
4
For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.对于患有杜克B期(TNM分期II期)结直肠癌的患者,检查六个或更少的淋巴结与预后不良有关。
Cancer. 1998 Aug 15;83(4):666-72.
5
Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined.结直肠肿瘤标本的淋巴结回收:关于建议检查的最少淋巴结数量
World J Surg. 2002 Mar;26(3):384-9. doi: 10.1007/s00268-001-0236-8. Epub 2002 Jan 15.
6
Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.日本根治性淋巴结清扫术对Dukes' B期和C期结直肠癌患者10年生存率的改善:一项17年的回顾性研究。
Oncol Rep. 2003 Jul-Aug;10(4):927-34.
7
Depletion of tumor-infiltrating macrophages is associated with amphoterin expression in colon cancer.肿瘤浸润巨噬细胞的耗竭与结肠癌中双调蛋白的表达相关。
Pathobiology. 2004;71(3):129-36. doi: 10.1159/000076467.
8
[Lymph node micrometastases and expression of metastasis-related gene proteins in patients with colorectal cancer].[结直肠癌患者的淋巴结微转移及转移相关基因蛋白的表达]
Zhonghua Wai Ke Za Zhi. 2006 Feb 1;44(3):181-5.
9
Suppression of dendritic cells by HMGB1 is associated with lymph node metastasis of human colon cancer.高迁移率族蛋白B1对树突状细胞的抑制作用与人结肠癌的淋巴结转移相关。
Pathobiology. 2009;76(4):155-62. doi: 10.1159/000218331. Epub 2009 Jun 29.
10
Number and size of lymph nodes recovered from dukes B rectal cancers: correlation with prognosis and histologic antitumor immune response.从杜克B期直肠癌中回收的淋巴结数量和大小:与预后及组织学抗肿瘤免疫反应的相关性
Dis Colon Rectum. 2007 Oct;50(10):1526-34. doi: 10.1007/s10350-007-9024-3.

引用本文的文献

1
The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy.自然杀伤细胞在肿瘤转移中的作用及基于自然杀伤细胞的免疫疗法
Cancers (Basel). 2023 Apr 16;15(8):2323. doi: 10.3390/cancers15082323.
2
MiR-216b functions as a tumor suppressor by targeting HMGB1-mediated JAK2/STAT3 signaling way in colorectal cancer.在结直肠癌中,miR-216b通过靶向HMGB1介导的JAK2/STAT3信号通路发挥肿瘤抑制作用。
Am J Cancer Res. 2017 Oct 1;7(10):2051-2069. eCollection 2017.
3
Expression levels and clinical significance of hepsin and HMGB1 proteins in cervical carcinoma.
肝素酶和高迁移率族蛋白B1(HMGB1)蛋白在宫颈癌中的表达水平及临床意义
Oncol Lett. 2017 Jul;14(1):159-164. doi: 10.3892/ol.2017.6116. Epub 2017 May 3.
4
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?自然杀伤细胞、肿瘤细胞转化与实体恶性肿瘤的进展:基于自然杀伤细胞的免疫治疗新线索?
J Immunol Res. 2016;2016:4684268. doi: 10.1155/2016/4684268. Epub 2016 May 12.
5
Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases.循环 HMGB1 和 RAGE 作为恶性和自身免疫性疾病的临床生物标志物。
Diagnostics (Basel). 2015 Jun 16;5(2):219-53. doi: 10.3390/diagnostics5020219.
6
The Role of HMGB1 Signaling Pathway in the Development and Progression of Hepatocellular Carcinoma: A Review.HMGB1信号通路在肝细胞癌发生发展中的作用:综述
Int J Mol Sci. 2015 Sep 17;16(9):22527-40. doi: 10.3390/ijms160922527.
7
High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.高迁移率族蛋白盒1在肝内胆管癌中的表达与淋巴结转移
World J Gastroenterol. 2015 Mar 21;21(11):3256-65. doi: 10.3748/wjg.v21.i11.3256.
8
Immunohistochemical detection of high-mobility group box 1 correlates with resistance of preoperative chemoradiotherapy for lower rectal cancer: a retrospective study.高迁移率族蛋白B1的免疫组化检测与低位直肠癌术前放化疗耐药的相关性:一项回顾性研究
World J Surg Oncol. 2015 Jan 27;13:7. doi: 10.1186/1477-7819-13-7.
9
Knockdown of HMGB1 improves apoptosis and suppresses proliferation and invasion of glioma cells.敲低高迁移率族蛋白B1可改善胶质瘤细胞的凋亡,并抑制其增殖和侵袭。
Chin J Cancer Res. 2014 Dec;26(6):658-68. doi: 10.3978/j.issn.1000-9604.2014.12.05.
10
HMGB1 in health and disease.健康与疾病中的高迁移率族蛋白B1(HMGB1)
Mol Aspects Med. 2014 Dec;40:1-116. doi: 10.1016/j.mam.2014.05.001. Epub 2014 Jul 8.